F. Kaiser

Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide

T. Knilans, A. Varró, D. A. Lathrop, 1991, Cardiovascular Drugs and Therapy.

ARL 15849: A Selective CCK-A Agonist With Anorectic Activity in the Rat and Dog

M. E. Pierson, F. Kaiser, R. Simmons, 1998, Pharmacology Biochemistry and Behavior.

Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.

E. Harris, R. Griffith, M. L. Stagnitto, 1995, The Journal of pharmacology and experimental therapeutics.

Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze.

R. Carr, L. Fraser-Rae, A. Wallace, 1992, Neuroreport.

Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents.

R. Julien, M. E. Pierson, F. Kaiser, 1997, Journal of medicinal chemistry.

Behavioral Effects of AR-R 15849, a Highly Selective CCK-A Agonist

T. Hudzik, F. Kaiser, R. Simmons, 1999, Pharmacology Biochemistry and Behavior.

CCK peptides with combined features of hexa- and tetrapeptide CCK-A agonists.

R. Julien, M. E. Pierson, F. Kaiser, 2000, Journal of Medicinal Chemistry.